BIO members Ginkgo Bioworks, Inc. and Bayer are in a multi-year strategic partnership to accelerate the research and development of synthetic biological products for agriculture. #ABCsofClimateTech Learn more: https://lnkd.in/eSv4WWud
Biotechnology Innovation Organization
Biotechnology Research
Washington, DC 91,602 followers
BIO, Where breakthroughs begin
About us
BIO is the world's largest biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. Our mission is to be the champion of biotechnology and the advocate for our member organizations—both large and small. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. We also represent state and regional biotech associations, service providers to the industry and academic centers.
- Website
-
http://www.bio.org
External link for Biotechnology Innovation Organization
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Washington, DC
- Type
- Nonprofit
- Founded
- 1993
- Specialties
- biotech, association, life sciences, biofuels, gmo, cures, energy, agriculture, and pharmaceuticals
Locations
-
Primary
1201 New York Ave N.W.
Suite 1300
Washington, DC 20005, US
Employees at Biotechnology Innovation Organization
Updates
-
Explore #NaturesBuildingBlocks through heartfelt and inspiring videos that explore how biotechnology creates solutions to our greatest challenges: sustainability, health, and inequality. #NaturesBuildingBlocks series is BIO’s second film series produced by BBC StoryWorks. https://lnkd.in/e9YK-XAt
-
Biotechnology Innovation Organization reposted this
As #BIO2024 has come to an end, our CEO, Monika Paule, shared how Caszyme's CRISPR solutions are advancing the field of biotechnology with the I am Bio podcast 🧬🚀 #CRISPR #geneediting
Chief Executive Officer at Caszyme, Vice President at LithuaniaBIO, Professional Board Member, Innovations Expert & Entrepreneur
It was an inspiring week at #BIO2024 in San Diego! Enjoyed sharing my take with BIO Podcast series. #CRISPR #geneediting #Caszyme
-
Biotechnology Innovation Organization reposted this
We celebrate Biotechnology Innovation Organization’s latest article featuring Immuto Scientific Co-Founders Faraz A. Choudhury, Ph.D., and Daniel Benjamin, Ph.D. “Our vision is to lead the industry in developing therapies that transform cancer from a life-threatening disease to a manageable condition, ultimately striving for a world where cancer is curable.” NIH SEED was proud to support Immuto Scientific at #BIO2024 after they received funding from National Institute of General Medical Sciences (NIGMS). Thank you for your unwavering dedication and effort toward making the world a better place! 🎗️ #StandUptoCancer #CancerAwareness #SEEDtheFuture Clary Estes https://ow.ly/QHls50SyYlx
-
The FTC released an interim report criticizing the negative impact that PBMs have on prescription drug prices. Key findings show market concentration of PBMs and their disproportionate power over drug prices and patient access. Read the full report: https://lnkd.in/eXQuDpim
-
Congratulations to BIO member Eli Lilly and Company on last week's FDA approval for their treatment of early symptomatic Alzheimer's Disease!
Breaking News: The FDA approved a new amyloid-targeting therapy to treat adults with early symptomatic #AlzheimersDisease. Learn more: https://e.lilly/4bsaOPk
-
BIO events are not the only opportunity for BIO members to save. Members have access to the largest cost-saving program for the life sciences industry, BIO Business Solutions®. Become a member today and start saving. https://lnkd.in/eisSxMNH
-
Latest op-ed by National Organization for Rare Disorders CEO Pamela Gavin: Congress must renew the Rare Pediatric Disease Voucher Program to continue advancing treatments for rare childhood diseases. Read more: https://lnkd.in/eVaBYnTx
The rare pediatric disease voucher program creates new treatments. I have new data to prove it
https://www.statnews.com
-
Biotechnology Innovation Organization reposted this
NEW Op-ed from NORD CEO Pamela Gavin in STAT: The pediatric #RareDisease voucher program successfully creates new treatments and MUST be reauthorized by Congress before September 30th. Read more: https://lnkd.in/eVaBYnTx
The rare pediatric disease voucher program creates new treatments. I have new data to prove it
https://www.statnews.com